Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection (STERAL)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Juan Macías, Andaluz Health Service
ClinicalTrials.gov Identifier:
NCT01900015
First received: July 12, 2013
Last updated: November 21, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)